State Street Corp Glaukos Corp Transaction History

State Street Corp

  • $2.47 Trillion
  • Q4 2024

A detailed history of State Street Corp transactions in Glaukos Corp stock. As of the latest transaction made, State Street Corp holds 2,063,399 shares of GKOS stock, worth $260 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,063,399
Previous 1,954,449 5.57%
Holding current value
$260 Million
Previous $255 Million 21.51%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$126.42 - $152.67 $13.8 Million - $16.6 Million
108,950 Added 5.57%
2,063,399 $309 Million
Q3 2024

Nov 14, 2024
BUY
$113.62 - $135.39 $11.1 Million - $13.3 Million
98,109 Added 5.29%
1,954,449 $255 Million
Q2 2024

Aug 14, 2024
BUY
$89.48 - $118.35 $2.74 Million - $3.63 Million
30,630 Added 1.68%
1,856,340 $220 Million
Q1 2024

May 15, 2024
BUY
$76.4 - $96.33 $672,243 - $847,607
8,799 Added 0.48%
1,825,710 $172 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $3.04 Million - $4.35 Million
51,104 Added 2.89%
1,816,911 $144 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $1.15 Million - $1.31 Million
-16,540 Reduced 0.93%
1,765,807 $133 Million
Q2 2023

Aug 14, 2023
BUY
$45.44 - $71.21 $1.43 Million - $2.24 Million
31,471 Added 1.8%
1,782,347 $127 Million
Q1 2023

May 15, 2023
BUY
$43.88 - $52.48 $1.96 Million - $2.34 Million
44,555 Added 2.61%
1,750,876 $87.7 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $430,610 - $609,204
10,549 Added 0.62%
1,706,321 $74.5 Million
Q3 2022

Nov 15, 2022
SELL
$46.84 - $58.49 $116,397 - $145,347
-2,485 Reduced 0.15%
1,695,772 $90.3 Million
Q2 2022

Aug 15, 2022
BUY
$34.86 - $63.77 $568,740 - $1.04 Million
16,315 Added 0.97%
1,698,257 $77.1 Million
Q1 2022

May 16, 2022
SELL
$44.33 - $57.82 $490,289 - $639,489
-11,060 Reduced 0.65%
1,681,942 $97.3 Million
Q4 2021

Feb 14, 2022
BUY
$40.27 - $56.99 $2.28 Million - $3.22 Million
56,547 Added 3.46%
1,693,002 $75.2 Million
Q3 2021

Nov 15, 2021
BUY
$47.43 - $84.23 $4.77 Million - $8.47 Million
100,524 Added 6.54%
1,636,455 $78.8 Million
Q2 2021

Aug 16, 2021
BUY
$73.06 - $97.7 $6.13 Million - $8.2 Million
83,953 Added 5.78%
1,535,931 $130 Million
Q1 2021

May 17, 2021
BUY
$70.43 - $97.42 $704,793 - $974,881
10,007 Added 0.69%
1,451,978 $122 Million
Q4 2020

Feb 16, 2021
BUY
$48.9 - $75.26 $649,098 - $999,001
13,274 Added 0.93%
1,441,971 $109 Million
Q3 2020

Nov 10, 2020
BUY
$37.23 - $50.97 $265,933 - $364,078
7,143 Added 0.5%
1,428,697 $70.7 Million
Q2 2020

Aug 14, 2020
BUY
$28.78 - $46.83 $2.81 Million - $4.57 Million
97,508 Added 7.36%
1,421,554 $54.6 Million
Q1 2020

May 11, 2020
BUY
$25.53 - $70.14 $33.8 Million - $92.9 Million
1,324,046 New
1,324,046 $40.9 Million

Others Institutions Holding GKOS

# of Institutions
354
Shares Held
50M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.99B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email